Su Jin Jun

Su Jin Jun

Auto-generated profile, based on publicly available information

Su Jin Jun

AI-based Neurodevelopmental Diseases Digital Therapeutics Group, Korea Brain Research Institute (KBRI), 61, Cheomdan-ro, Daegu, 41062, Republic of Korea

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
14 October 2025 in JMIR Serious Games
Verified
Journal Article
Open access
JKJun-Su Kim
Jun-Su Kim
YJYoo Joo Jeong
Yoo Joo Jeong
SKSeung-Jae Kim
Seung-Jae Kim
SJSu Jin Jun
Su Jin Jun
JPJin-Yeop Park
Jin-Yeop Park
JSJeong-Heon Song
Jeong-Heon Song
Background: The processing speed index (PSI) of the Korean Wechsler Intelligence Scale for Children-Fifth Edition (K-WISC-V) is highly correlated with symptoms of attention-deficit/hyperactivity disorder (ADHD) and is an important indicator of cognitive function. However, restrictions on the frequency of testing prevent short-term PSI assessments. An accessible, objective technique for predicting PSI scores would enable better short-term monitoring and intervention for children with ADHD. Objective: To enable objective and accessible monitoring of cognitive function beyond traditional clinical assessments, this study aimed to develop a machine learning model that predicts the PSI scores of children with ADHD using behavioral data from serious games. Methods: Sixty-eight children (6-13 y of age) with ADHD were recruited, and after excluding incomplete data, 59 participants were included in the final analysis. The participants completed an initial PSI assessment using the K-WISC-V followed by 25 minutes of engagement with serious game content. Data from the game sessions were used to train machine learning models, and the models’ performance in predicting PSI scores was evaluated using the root mean squared error (RMSE), mean absolute error (MAE), and mean absolute percent error (MAPE), with K-fold cross-validation (k=4) applied to ensure robustness. Results: Among the individual machine learning models, support vector regression (SVR) had the best performance, with the lowest RMSE of 11.288, MAE of 7.874, and MAPE of 7.375%. The best overall performance was achieved by the ensemble integrating AdaBoost, Elastic Net, and SVR, which recorded the lowest RMSE of 10.072, MAE of 6.798, and MAPE of 6.611%. The predictive accuracy of this ensemble model was highest for PSI scores near the mean value of 100, demonstrating its reliability for clinical applications. Conclusions: The developed PSI prediction model has the potential to serve as an objective and accessible tool for monitoring cognitive function in children with ADHD. As a complement to traditional assessments, this approach allows continuous tracking of symptom changes and can support more personalized treatment planning in both clinical and everyday settings, which may improve accessibility and adherence. However, the findings need to be validated in larger, more diverse populations, and the long-term feasibility of using serious games in clinical and educational settings must be further examined.

11 March 2025 in Clinical Pharmacology & Therapeutics
Verified
Journal Article
Open access
HLHyunju Lee
Hyunju Lee
YJYoo Joo Jeong
Yoo Joo Jeong
JKJun‐Su Kim
Jun‐Su Kim
SKSeung‐Jae Kim
Seung‐Jae Kim
UJUnhui Jo
Unhui Jo
HHHyang-Sook Hoe
Hyang-Sook Hoe
Innovations in digital technologies have emerged digital therapeutics (DTx) as a novel therapeutic intervention. DTx hold potential as novel theragnostics for disorders with broad diagnostic spectra, including neurodevelopmental diseases (NDDs). In this review, we highlight challenging factors in the successful development and deployment of DTx for NDDs with respect to patients, medical professionals, and manufacturers. We also discuss the implications of these factors and future directions for revitalizing DTx development for NDDs.

31 July 2025 in Medicinal Research Reviews
Verified
Journal Article
Open access
YJYoo Joo Jeong
Yoo Joo Jeong
HLHyunju Lee
Hyunju Lee
JKJun‐Su Kim
Jun‐Su Kim
SKSeung‐Jae Kim
Seung‐Jae Kim
UJUnhui Jo
Unhui Jo
HHHyang-Sook Hoe
Hyang-Sook Hoe
Alzheimer's disease (AD) and Parkinson's disease (PD), which are characterized by the accumulation of misfolded protein aggregates and cognitive/motor dysfunction, are the most prevalent neurodegenerative diseases (NDDs). Despite strategic investigations aimed at augmenting the pharmaceutical pipeline, available drugs for AD and PD merely slow disease progression without curing or treating the underlying pathology. Recent technological advances have given rise to digital therapeutics (DTx): software systems that aim to prevent, cure, and manage specific diseases, including NDDs. For AD and PD, the majority of DTx focus on enhancing cognitive/executive function and motor‐related functions, respectively. In this review, we describe the status of therapeutic development for AD and PD, as well as the characteristics and status of DTx targeting these NDDs. In addition, we address the limitations and challenges of DTx and their implications for the treatment of AD and PD. Ultimately, this review provides insights into the potential of DTx as a therapeutic modality and future directions for the development of DTx targeting AD and PD.

11 June 2026 in JMIR Serious Games
Verified
Journal Article
Open access
JKJun-Su Kim
Jun-Su Kim
SKSeung-Jae Kim
Seung-Jae Kim
GRGilnam Ryu
Gilnam Ryu
SJSu-Jin Jun
Su-Jin Jun
JPJin-Yeop Park
Jin-Yeop Park
HHHyang-Sook Hoe
Hyang-Sook Hoe
Background: Recent advances in digital therapeutics (DTx) have led to the development of game-based, home-delivered interventions for children with attention-deficit/hyperactivity disorder (ADHD). Prior studies have demonstrated the feasibility and clinical potential of DTx for reducing ADHD symptoms but have primarily evaluated usage metrics, including training frequency and duration, which do not capture in-game performance or learning processes during training. In addition, the association between task difficulty regulation during DTx training and ADHD symptom improvement in children has not been well studied. Objective: This study aimed to examine whether task difficulty regulation during DTx training is associated with ADHD symptom improvement in children and to evaluate the clinical relevance of difficulty-related behavioral measures as indicators of treatment response. Methods: In this study, a secondary post hoc analysis of data from 35 children aged 6 to 13 years with ADHD who participated in a randomized controlled trial was performed. The participants had completed a 4-week training program comprising 5 digital cognitive tasks from the DTx Neuro-World. During training, task difficulty was automatically adjusted in real time according to participants’ response accuracy to maintain an appropriate challenge level. Training difficulty was quantified by 3 indices: average task difficulty, task difficulty variability, and task difficulty slope. Associations between difficulty indicators and ADHD symptom changes were examined using regression analyses and group comparisons. Results: We found that lower average task difficulty during tasks 1, 2, and 4 of Neuro-World was associated with improvements in ADHD symptoms, as assessed by the total Korean-ADHD Rating Scale (K-ARS) score. In addition, the average task difficulty of tasks 1 to 4 was related to improvements in hyperactivity/impulsivity symptoms of ADHD, as assessed by the K-ARS hyperactivity or impulsivity subscore, but not to improvements in inattention symptoms. Moreover, lower variability of task difficulty in task 5 improved ADHD hyperactivity/impulsivity symptoms, as assessed by K-ARS, but did not affect Korean-Child Behavior Checklist scores. Finally, we found that a negative task difficulty slope was associated with the alleviation of ADHD hyperactivity or impulsivity. These findings should be interpreted with caution, given the exploratory nature of the study and the absence of formal correction for multiple comparisons. Conclusions: As an exploratory investigation, our study provides a novel perspective by demonstrating that individualized and stable regulation of task difficulty, rather than the mere attainment of higher difficulty levels, is associated with ADHD symptom improvement. These findings indicate that dynamic difficulty trajectories derived from in-game behavioral data are clinically relevant, going beyond the conventional focus in the literature on usage metrics or overall training intensity. Our results support the role of individualized difficulty trajectories as potential digital biomarkers of clinical response. This approach has important implications for the design of DTx that incorporate personalized and adaptive difficulty regulation to enhance clinical effectiveness and scalability.

22 December 2025 in JMIR Serious Games
Verified
Journal Article
Open access
JKJun-Su Kim
Jun-Su Kim
YJYoo Joo Jeong
Yoo Joo Jeong
SKSeung-Jae Kim
Seung-Jae Kim
SJSu Jin Jun
Su Jin Jun
JPJin-Yeop Park
Jin-Yeop Park
JSJeong-Heon Song
Jeong-Heon Song
Journal of Medical Internet Research - International Scientific Journal for Medical Research, Information and Communication on the Internet #Preprint #PeerReviewMe: Warning: This is a unreviewed preprint. Readers are warned that the document has not been peer-reviewed by expert/patient reviewers or an academic editor, may contain misleading claims, and is likely to undergo changes before final publication, if accepted, or may have been rejected/withdrawn. Readers with interest and expertise are encouraged to sign up as peer-reviewer, if the paper is within an open peer-review period. Please cite this preprint only for review purposes or for grant applications and CVs (if you are the author).